Minimal change disease associated with newly diagnosed mantle cell lymphoma

Kareeann Khow, Angelina Yong, Tuck Yong, Bryone Kuss, Jeffrey Barbara, Jordan Li

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)


    Mantle cell lymphoma (MCL) is a rare but aggressive form of non-Hodgkin's lymphoma. Involvement of the kidney is an infrequent occurrence in patients with MCL and can be the result of direct infiltration or paraneoplastic glomerulopathy. Proliferative glomerulonephritis, membranoproliferative glomerulonephritis and focal segmental glomerulosclerosis have previously been reported in association with MCL. We report a 55-year-old woman who developed nephrotic syndrome due to biopsy proven minimal change disease (MCD) in association with MCL. Proteinuria decreased with prednisolone treatment and MCD remains in remission without any immunosuppressant after the treatment of the underlying MCL.

    Original languageEnglish
    Pages (from-to)634-637
    Number of pages4
    JournalRenal Failure
    Issue number4
    Publication statusPublished - May 2014


    • Mantle cell lymphoma
    • Minimal change disease
    • Nephrotic syndrome
    • Paraneoplastic glomerulopathy


    Dive into the research topics of 'Minimal change disease associated with newly diagnosed mantle cell lymphoma'. Together they form a unique fingerprint.

    Cite this